You focus on generics and biosimilars
So do we ...
Let us bring you the news that matters to your industry.
Don't waste time sifting through pharma noise. Generics bulletin delivers all the information you need to make better decisions faster.
Join thousands of subscribers from companies in nearly 60 countries who are already benefitting from commercial intelligence about business opportunities in the global generic medicines and biosimilars markets.
Accurate and reliable news reports reveal the strategies of the world's leading generics companies and analyse their business performance, plans and portfolios.
And a searchable archive offers an invaluable resource for researching market opportunities, benchmarking competitive strengths, evaluating regulatory changes and assessing product developments.
Take out your own subscription today
An annual subscription comprises:
- 46 Generics bulletin online editions – published on Fridays
- a searchable archive
- 46 optional hard-copy print editions, delivered by airmail.
Choice of formats
Generics bulletin can be accessed from:
- Desktop and laptop computers AND
- Apple and Android tablets and smartphones.
Discounts are available for multiple subscriptions for colleagues. See subscription rates.
Corporate Subscriptions provide location-, country- or company-wide access. Contact subscriptions@Generics-bulletin.com for further details.